Primary goal: To evaluate the monocular & binocular visual acuity for far, intermediate and near distance after the INTENSITY implantation.
Secondary goals: To measure the defocus curve and patient satisfaction.
Prof. Ehud I. Assia Hanita Lenses
This study is a prospective, single arm, single center, open label study.
The aim of this study is to evaluate safety and performance of the INTENSITY IOL.
Patients diagnosed with cataract who require cataract surgery procedure that meet the inclusion criteria.
Age 45 – 75 years.
Bilateral age-related cataracts, require bilateral cataract.
Axial length of 22-24.5mm.
Corneal astigmatism < 0.75D, regular.
Post-op BCVA expected 0.3 logMAR or better.
Patient motivated for multifocal IOL
No retinal or optic nerve abnormalities
Study status
Parameter | Average |
---|---|
SE [D] | - 0.24 |
UDVA [LogMAR] | 0.56 |
CDVA [LogMAR] | 0.18 |
K1 [D] | 43.51 |
K2 [D] | 43.96 |
Cyl [D] | 0.45 |
AL [mm] | 23.34 |
Spherical Equivalence
3 Months post-op, n=40
Monocular Uncorreced Visual Acuity
3 Months post-op, n=40
Monocular Correced Visual Acuity
3 Months post-op, n=40
Binocular Correced Visual Acuity
3 Months post-op, n=40
Contrast sensitivity
3 Months post-op, n=40
Spherical Equivalence
3 Months post, n=40
Uncorrected: Distance – Intermediate – Near
1-3 Months post-op Uncorrected, n=26
Visual acuity
1-3 Months post-op Corrected, n=26
Visual acuity
3 Months post-op, n=40
Contrast sensitivity
Results show an excellent defocus curve, with exceptionally good near and intermediate vision without compromising the far vision.
Average visual acuity above 0.05 (6/6.7) throughout infinity to 40 cm.
To find out more about the product, contact us by filling out the form
Hanita Lenses
Hanita is a global leader in
innovative solutions for cataract